HCV quant assay, aptima, 100-test, US IVD

The Florida Department of Health has awarded contract C7672A for the procurement of hepatitis C virus (HCV) quantitative assay reagents. The contract is valued at $75,000.00 and covers the delivery of 25 units of Aptima HCV quantitative assay kits, each containing 100 tests and designated for use as in vitro diagnostic (IVD) devices. The contract period runs from July 1, 2026, through June 30, 2027, with a unit price of $3,000.00 per kit.

The award supports the Department of Health's laboratory diagnostic capabilities for hepatitis C virus quantification testing. These Aptima-brand assay kits are medical diagnostic products utilized in clinical and public health laboratory settings to measure viral load in patients with HCV infection. The procurement enables the state health department to maintain adequate supplies of validated diagnostic reagents to support its infectious disease testing and surveillance operations throughout the contract period.